Additionally, there was a notable reduction in the levels of not only stem cell markers CD133 (Figure 4A) and CD44 (Figure 4B), but also the stem cell transcription factor OCT4, (Figure 4B) compared to spheroids treated with RT (50 nM) in lung cancer. This evidence concerns the gene PROM1 and lung cancer.